Miami‑based private‑equity firm Mako Capital Group launched this week, positioning itself in the lower‑middle‑market segment of U.S. healthcare, financial and other service businesses. The founders—Angel Morales, Pete Amaro and Oscar Munoz—plan to target companies generating $5 million to $15 million of EBITDA, committing between $25 million and $50 million of equity per deal. Such capital depth allows Mako to take controlling stakes while leaving founders operational control.

The firm’s inaugural investment landed in Mangrove Health, a Miami platform that delivers preventive, community‑based care services. While the transaction terms were not disclosed, the backing signals confidence in a business model that blends telehealth, home visits and health monitoring. Investors see such providers as positioned to capture rising demand for outpatient solutions. The deal also opens doors to Mako’s executive network.

By targeting EBITDA ranges of $5‑$15 million, Mako aims to fill a financing gap left by larger buyout firms that chase $100 million‑plus targets. The strategy could accelerate consolidation among niche health‑service operators, giving them scale to negotiate payer contracts and invest in technology. Mangrove Health now becomes a benchmark for Mako’s playbook. If the partnership yields measurable cost savings, other regional providers may seek similar equity backing.